Jagdish K. Racha

Discovery of Piragliatin—First Glucokinase Activator Studied in Type 2 Diabetic Patients

Ramakanth Sarabu, Fred T. Bizzarro, Wendy L. Corbett et al. · Journal of Medicinal Chemistry · 2012 · 98 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Automated high throughput human CYP isoform activity assay using SPE-LC/MS method: application in CYP inhibition evaluation

H L Yin, Jagdish K. Racha, Sophia Li et al. · Xenobiotica · 2000 · 66 citations

Medicine, Pharmacokinetics, Pharmacology +17

Mechanism-Based Inactivation of Human Cytochrome P450 1A2 by Furafylline:  Detection of a 1:1 Adduct to Protein and Evidence for the Formation of a Novel Imidazomethide Intermediate

Jagdish K. Racha, Allan E. Rettie, Kent L. Kunze · Biochemistry · 1998 · 66 citations

Medicine, Biochemistry, Pharmacology +16

Substrate Dependent Inhibition Profiles of Fourteen Drugs on CYP3A4 Activity Measured by A High Throughput LCMS/MS Method with Four Probe Drugs, Midazolam, Testosterone, Nifedipine and Terfenadine

Jagdish K. Racha, Zhen Zhao, Nicholas Olejnik et al. · Drug Metabolism and Pharmacokinetics · 2003 · 45 citations

Medicine, Pharmacokinetics, Pharmacology +11

A single‐dose mass balance and metabolite‐profiling study of vemurafenib in patients with metastatic melanoma

Simone M. Goldinger, Jeannine D. Rinderknecht, Reinhard Dummer et al. · Pharmacology Research & Perspectives · 2015 · 28 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15